Evaluation of the Transwell System for Characterization of Dissolution Behavior of Inhalation Drugs: Effects of Membrane and Surfactant.

  title={Evaluation of the Transwell System for Characterization of Dissolution Behavior of Inhalation Drugs: Effects of Membrane and Surfactant.},
  author={Marc Rohrschneider and Sharvari Bhagwat and R. Krampe and V. Michler and J. Breitkreutz and G. Hochhaus},
  journal={Molecular pharmaceutics},
  volume={12 8},
  • Marc Rohrschneider, Sharvari Bhagwat, +3 authors G. Hochhaus
  • Published 2015
  • Chemistry, Medicine
  • Molecular pharmaceutics
  • Assessing the dissolution behavior of orally inhaled drug products (OIDs) has been proposed as an additional in vitro test for the characterization of innovator and generic drug development. A number of suggested dissolution methods (e.g., commercially available Transwell or Franz cell systems) have in common a membrane which provides the separation between the donor compartment, containing nondissolved drug particles, and an acceptor (sampling) compartment into which dissolved drug will… CONTINUE READING
    31 Citations

    Figures, Tables, and Topics from this paper

    Towards Standardized Dissolution Techniques for In Vitro Performance Testing of Dry Powder Inhalers
    • 10
    • Highly Influenced
    • PDF
    Development of an In Vitro System to Study the Interactions of Aerosolized Drugs with Pulmonary Mucus
    • 4
    • PDF
    DissolvIt: An In Vitro Method for Simulating the Dissolution and Absorption of Inhaled Dry Powder Drugs in the Lungs.
    • 17
    • PDF
    Dry powder inhalers: An overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products
    • S. Velaga, J. Djuriš, +4 authors A. Rossi
    • Chemistry, Medicine
    • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
    • 2018
    • 23
    • Highly Influenced
    Ciclesonide and budesonide suspensions for nebulization delivery: An in vivo inhalation biopharmaceutics investigation
    • 3
    • Highly Influenced
    Predicting Pulmonary Pharmacokinetics from In Vitro Properties of Dry Powder Inhalers
    • 13


    Optimization of an In Vitro Dissolution Test Method for Inhalation Formulations
    • 47
    • PDF
    Challenges with Developing In Vitro Dissolution Tests for Orally Inhaled Products (OIPs)
    • 58
    • Highly Influential
    Development of a standardized dissolution test method for inhaled pharmaceutical formulations.
    • 88
    A novel method for assessing dissolution of aerosol inhaler products.
    • 143
    Dissolution Techniques for In Vitro Testing of Dry Powders for Inhalation
    • 54
    • PDF
    In Vitro Aqueous Fluid-Capacity-Limited Dissolution Testing of Respirable Aerosol Drug Particles Generated from Inhaler Products
    • 47
    Note: dissolution of aerosol particles of budesonide in Survanta, a model lung surfactant.
    • 46
    Slow Release Formulations of Inhaled Rifampin
    • 56